Lyft and Continuum Partner for Clinical Trial Transportation That Could Literally Save Your Life
What if you could save someone’s life simply by a common-sense partnership between one of the largest ride-sharing companies and a pharmaceutical clinical trial company? Well, that’s exactly what they’ve done, to the benefit of potentially hundreds of patients.
In an effort to increase participation in their pharmaceutical clinical trials, Continuum Clinical will partner with Lyft to provide free transportation for their patients. Participants often miss appointments or are forced to drop out of trials due to the lack of reliable transportation to and from the trial site.
“We’re thrilled to partner with Lyft to offer patients enrolled in clinical trials a new level of convenience,” said Nariman Nasser, vice president of site optimization at Continuum Clinical. “We believe that this service will make enrolling and staying in a study easier, especially for those patients with limited resources and access to transportation.”
This initiative is a first of its kind to help insure patients who are enrolled in a study will complete the program, thus increasing the usable data available for the pharmaceutical company. The pilot program will launch this quarter with a national study on lupus. Patients will use the Lyft app to book their rides to and from the trial site, free of charge.
“Through our partnership with Continuum Clinical, we’re able to provide patients with safe, affordable and reliable rides,” said Gyre Renwick, head of enterprise healthcare partnerships at Lyft. “We look forward to working with Continuum to help the community get around more efficiently.”
This is the second-time Lyft has partnered with the medical community. In 2016 they started providing mobility solutions for senior care providers and healthcare systems for non-emergency transportation services through their Ride with Care program.